Introduction {#s1}
============

Progressive improvements in genetic selection and nutritional strategies in meat broilers to grow them faster have exerted these broiler strains subject to various physiological stresses ([@B1], [@B2]). This has also resulted in emergence of several muscle myopathies including one called woody breast (WB) myopathy. This myopathy condition affects the *Pectoralis major* (poultry breast) muscle ([@B3], [@B4]). A recent study reported WB myopathy incidence of \~9% for 10,483 filets evaluated in high breast meat yielding strain from a flock which produced larger broilers (2.72--4.53 kg) ([@B5]). The WB affected filet is phenotypically stiff and visually unappealing along with reduced protein quality. Histologically, it has been reported to exhibit moderate to severe polyphasic myodegeneration with variable degrees of interstitial connective tissue accretion or fibrosis ([@B6]).

The exact biological mechanism for causation of this myopathy is still unclear to scientific community, while many studies have been conducted particularly in past 5-year span to understand its associated etio-pathophysiological processes ([@B3], [@B7], [@B8]). This study is another attempt to understand myopathy bird from non-myopathy ones with the goal of characterizing physiological perturbations undergoing in this diseased condition. Here, we were interested in characterizing heat production (**HP**) and body composition (**BC**) differences in these two groups to understand if there is disparity in dietary nutrient utilization and its partitioning in myopathy state. We utilized metabolic chambers to measure HP, and Dual Energy X-ray Absorptiometry (**DEXA**) to predict BC. This is the first study undertaken to characterize myopathy and non-myopathy broilers for HP changes to our knowledge. Simultaneously, we also evaluated microbiota differences in ileal digesta, and measured differential expression of plasma metabolites to uncover associated biomarkers in comprehending possible etio-pathology involved in this myopathy condition.

Methods {#s2}
=======

Bird Type, Husbandry, and Sampling
----------------------------------

The experiment was conducted in a fast-growing commercial meat type broiler strain, *Gallus gallus domesticus*, in its finishing grow-out phase, grown feeding in floor pens with recommended nutrient guidelines as per the strain requirement ([Table 1](#T1){ref-type="table"}). Broilers were randomly selected and scored for WB myopathy from the scale of 0--3, 0 being the non-myopathy broiler and 3 being the severely affected myopathy broiler ([@B9]) at d 41. Therefore, two treatment groups- myopathy and non-myopathy were created. For each group of non-myopathy (WB score \< 1) and myopathy (*n* ≥ 2), *n* = 20 birds were selected with 40 birds utilized in the study. Twelve broilers, each treatment group, were then utilized for HP study. Remaining eight broilers for each category were then utilized for BC study. Bird used for the BC study were also sampled for histology (breast tissue), ileal digesta and blood samples. Tissue sample was fixed in 10 % formalin solution until subjected for histological slide preparation (Masson Trichome staining) and visualized using light microscopy (results only mentioned in discussion section). Ileal digesta (*n* = 8 each group) collected was immediately frozen with liquid N2. Plasma (*n* = 8 each group) was separated from blood samples. Digesta and plasma samples were then stored at −79°C until analysis. Ileal digesta were subjected for microbiota study, whereas blood samples were utilized for plasma metabolite analysis. The procedures for microbiota and metabolite study are explained in detail in the methods below.

###### 

Experimental finisher diet composition.

  **Ingredient**             **%**
  -------------------------- -------
  Corn                       66.66
  SBM                        27.89
  Dicalcium phosphate        1.49
  Limestone                  0.82
  Corn oil                   1.96
  Salt                       0.35
  DL-Methionine              0.23
  L-lysine                   0.15
  L-Threonine 98%            0.01
  Trace mineral              0.1
  Vitamins premix            0.1
  Ark phytase                0.05
  Kemin Mold curb-50%        0.05
  Selenium premix-0.06%      0.02
  Monsanto sanoquin 6 etho   0.02
  **Calculated values**      
  ME (Kcal/kg)               3,100
  CP                         18.77
  Dig Lysine                 1.00
  Dig Methionine             0.49
  Dig C+M                    0.76
  Dig Threonine              0.65

*Supplies per kilogram of diet: antioxidant, 200 mg; retinyl acetate, 21 mg; cholecalciferol, 110 μg; D-α-tocopherol acetate, 132 mg; menadione, 6 mg; riboflavin, 15.6 mg; D-calcium pantothenate, 23.8 mg; niacin, 92.6 mg; folic acid, 7.1 mg; cyanocobalamin, 0.032 mg; pyridoxine, 22 mg; biotin, 0.66 mg; thiamine, 3.7 mg; choline chlorine, 1,200 mg; Mn, 100 mg; Mg, 27 mg; Zn, 100 mg; Fe, 50 mg; Cu, 10 mg; I, 1 mg; Se, 200 μg. Axtra Phytase. Included at a rate of 50 g/MT to the basal diet to supply a guaranteed minimum of 500 FTY/kg of feed*.

Heat Production and Body Composition
------------------------------------

### Heat Production

Heat production was measured following the principle of indirect calorimetry system utilizing respiratory chambers. Each chamber (*n* = 2 birds) acted as a replicate of a treatment group. There were six replicates for each treatment group, with 12 chambers being utilized in the study. The same respiratory chambers units described in Caldas et al. ([@B10]) were utilized in the study to measure oxygen consumption (VO~2~) and carbon dioxide (VCO~2~) production per day at 41--43 d. The birds after moving to chambers were acclimatized for 24 h. The calibration of the gas measurement chamber units was performed at the beginning of experiment. Feed consumed per bird were accounted during the experimental period. The gas evaluation in each chamber was measured every 12 min, so every chamber unit provided 5 readings for 1 h, totaling 120 readings per day. Fed HP and fasting HP were measured each for 24 h utilizing the equations described below.

The VO~2~ and VCO~2~ obtained in liter (L)/d was the utilized to calculate HP using the following equation ([@B11]): HP, Kcal/d = 3.866 VO~2~ L/d + 1.233 VCO~2~ L/d.

Heat production was then adjusted to per unit metabolic BW per day. Heat increment (HI) was also accounted as HI = Fed HP- fasted HP.

### Body Composition

Broilers (*n* = 8) selected were scanned for BC study using DEXA equipped with Lunar Prodigy small animal software. Scanned values were used in previously determined equations ([@B12]) to calculate BC in terms of protein mass, and fat mass in treatment broilers; and protein to fat ratio were recorded.

### Data Analysis

The data obtained for HP and BC were analyzed by one-way ANOVA using JMPro 14 (SAS Institute, Inc., Cary, NC). Mean values were obtained for variables measured (HP, and protein to fat mass ratio). Significant means for the measured variables were separated using student\'s *t*-test or HSD test where appropriate. Means were considered significant for *P* ≤ 0.05.

Microbiota Analysis
-------------------

### DNA Extraction, PCR, Sequencing, and Sequence Processing

Bacterial DNA were extracted from ileal digesta using MoBio PowerMag Soil DNA Isolating Bead Plate. Following DNA extraction, bacterial 16S rRNA genes were PCR-amplified with dual-barcoded primers targeting the V4 region (515F 5′-GTGCCAGCMGCCGCGGTAA-3′, and 806R 5′-GGACTACHVGGGTWTCTAAT-3′ ([@B13]). Using the 300-bp paired-end kit (v.3), amplicons were then sequenced with an Illumina MiSeq. Sequences obtained were denoised, and taxonomically classified using Greengenes (v. 13_8) as the reference database. Classified sequences were clustered into 97%-similarity operational taxonomic units (OTUs) with the mothur software package (v. 1.39.5) ([@B14]). The potential for contamination was addressed by co-sequencing DNA amplified from specimens and from 2 each of template-free controls and extraction kit reagents processed the same way as the specimens. Operational taxonomic units were considered putative contaminants (and were removed) if their mean abundance in controls reached or exceeded 25 % of their mean abundance in specimens.

### Alpha and Beta Diversity Measurements and Data Analysis

Shannon index on raw OTU abundance tables were utilized to estimate alpha diversity. The significance of diversity differences was tested with ANOVA. To estimate beta diversity across samples, OTUs occurring with a count of \<3 in at least 10% of the samples were excluded and then computed Bray-Curtis indices. Beta diversity was visualized emphasizing differences across samples, using Principal Coordinate Analysis (PCoA) ordination. Variation in community structure was assessed with permutational multivariate analyses of variance (PERMANOVA) with treatment group as the main fixed factor and using 9,999 permutations for significance testing. The analyses were conducted in the R environment.

LC-MS Targeted Metabolomics
---------------------------

Targeted metabolomics of polar, primary metabolites was performed on a TQ-XS triple quadrupole mass spectrometer (MS) coupled to an I-class UPLC system (Waters) for differential expression. Plasma was thawed on ice then 80 μL was aliquoted to a 1.5 mL Eppendorf tube on ice. Next, 240 μL of ice-cold methanol was added and samples were vortexed to mix. Samples were incubated for 30 min at −80° C, and then centrifuged at 16,000 × g at 4°C for 15 min. The supernatant was analyzed by LC-MS. Separations were carried out on a ZIC-pHILIC column (2.1 × 150 mm, 5 μM) (EMD Millipore). The mobile phases were (A) water with 15 mM ammonium bicarbonate adjusted to pH 9.6 with ammonium hydroxide and (B) acetonitrile. The flow rate was 200 μL/min and the column were held at 50°C. The injection volume was 1 μL. The gradient was as follows: 0 min, 90% B; 1.5 min, 90% B; 16 min, 20% B; 18 min, 20% B; 20 min, 90% B; 28 min, 90% B. The MS was operated in selected reaction monitoring (SRM) mode. Source and desolvation temperatures were 150 and 600°C, respectively. Desolvation gas was set to 1,100 L/h and cone gas to 150 L/h. Collision gas was set to 0.15 mL/min. All gases were nitrogen except the collision gas, which was argon. Capillary voltage was 1 kV in positive ion mode and 2 kV in negative ion mode.

### Data Processing and Bioinformatics Analyses

Data obtained were normalized to total ion abundance. Coefficient of variance \>30% in the quality control injections were removed. Mass spectral metabolite databases were searched against including Metlin, Mass Bank of North America, and an in-house database. Data was processed using Skyline software ([@B15]).

Results {#s3}
=======

Heat Production and Body Composition
------------------------------------

### Heat Production

Heat production changes between myopathy and non-myopathy birds are given in [Figures 1A--C](#F1){ref-type="fig"}. Fed HP was 100.32 Kcal/kg^0.75^/d for myopathy broiler whereas it was 107.29 Kcal/kg^0.75^/d for non-myopathy (*P* \> 0.05). Fasting HP was 73.91 Kca//kg^0.75^/d for myopathy broiler whereas it was higher for non-myopathy 79.63 Kcal/kg^0.75^/d (*P* \< 0.05). Heat increment was 27.66 Kcal/kg^0.75^/d for non-myopathy and 26.41 Kcal/kg^0.75^/d for myopathy broiler. RER recorded for fed and fasted states were 0.8795 and 0.8731, and 0.7269 and 0.722070 for myopathy and non-myopathy, respectively.

![Heat production for myopathy and non-myopathy broiler at finishing phase (d 41). **(A)** Fed HP **(B)** Fasted HP **(C)** Heat increment. Asterisk on the top of the bar represent significanlty different mean values.](fvets-06-00497-g0001){#F1}

[Figure 2](#F2){ref-type="fig"} gives body composition data for myopathy and non-myopathy birds in terms of protein: fat ratio. The median value of protein to fat ratio for myopathy was 2.0 whereas it was 2.1 for non-myopathy.

![Body composition in terms of protein to fat ratio for myopathy and non-myopathy broiler. *N* = 8 for each treatment group.](fvets-06-00497-g0002){#F2}

Microbiota
----------

At phylum level, the predominant taxa identified were firmicutes in both myopathy (99.93%) and non-myopathy (98.56%) groups, followed by proteobacteria, 0.043% and 1.414%, and actinobacteria 0.021 and 0.0157%, respectively. Further, *Lactobacillus* was single most predominant species occupying more than 90% of bacterial population for both the treatment groups. At genus level, unclassified *Lactobacillus* was predominant (60.09%) with myopathy group whereas it was 21.84% in non-myopathy. At the species level, *L. acidipiscis* was predominant bacteria for non-myopathy birds (68.16%) ([Figure 3](#F3){ref-type="fig"}). Alpha diversity was numerically higher for myopathy birds than non-myopathy as indicated by Shannon Diversity Index ([Figure 4A](#F4){ref-type="fig"}). Beta diversity was near to significance (*P* = 0.058) with myopathy birds exhibiting greater sample-to-sample dissimilarity ([Figure 4B](#F4){ref-type="fig"}).

![Taxonomic bar plot. Each bar (R1--R6 replicate samples) for myopathy (M) and non-myopathy (NM) represents distribution of the aggregated taxa for each taxonomic rank in proportions. s, species; g, genus; o, order; f, family; and p, phylum. Non-myopathy group has relatively higher abundance of *Lactobacillus acidipiscis* (NM = 68.16%; and M = 34.90% of total abundance); whereas myopathy group has higher proportion of unclassifed generic *Lactobacillus* (M = 60.09%; and NM = 21.84% of total abundance).](fvets-06-00497-g0003){#F3}

![**(A)** Alpha diversity as given by Shannon diversity index for myopathy and non-myopathy broiler. **(B)** Beta-divesity or PCoA ordination as performed by Bray-Curtis dissimilarities.](fvets-06-00497-g0004){#F4}

Differential Expression of Plasma Metabolites
---------------------------------------------

Differentially significant metabolites captured in plasma samples of myopathy and non-myopathy broiler were presented in [Figure 5](#F5){ref-type="fig"}. Differentially significant metabolites (*P* \< 0.05) identified between these two treatment groups were homocysteine, cyclic GMP, trimethylamine N-oxide (TMAO), tyramine, carnitine, and acetylcarnitine, which were all associated to cardiovascular system. Homocysteine, TMAO, tyramine, carnitine, and aceltycarnitine were elevated in myopathy-affected broilers, whereas cyclic GMP was higher in non-myopathy group. Three-methyl histidine, a marker that is related to myofibrillar muscle breakdown, was expressed higher in plasma in myopathy bird than non-myopathy.

![Percent increase or decrease for differentially significant (*P* \< 0.05) metabolites in plasma samples of myopathy bird in relation to non-myopathy.](fvets-06-00497-g0005){#F5}

Discussion {#s4}
==========

Various metabolic disorders are evident in meat broilers, mainly arising from adverse response to vast genetic advancement in growth rate and meat yield. Of many metabolic and physiological perturbations that meat broilers encountered, it was predicted that skeletal muscle related metabolic disorder could remain as a major challenge for poultry industry ([@B16]). The industry is witnessing the myopathy condition, called WB myopathy, which is of idiopathic origin. In this study, we characterized HP differences utilizing indirect calorimetry between myopathy and non-myopathy type broilers while simultaneously studying BC. In indirect calorimetry, gas exchange (VO2 and VCO2) is measured as result of oxidation of energy substrates, and HP is then calculated from the substrate oxidation stoichiometry. Higher HP (fed or fasted) measured for non-myopathy bird was higher (*P* \< 0.05) could be due to higher the maintenance energy requirement for non-myopathy bird than myopathy bird. This greater maintenance HP could be coming from the higher protein content in body as indicated by higher protein: fat ratio in non-myopathy bird; as maintaining greater basal protein amount would require greater energy ([@B17], [@B18]). Lower body protein content in myopathy bird could be arising from higher skeletal mixed muscle protein degradation rates occurring in these type of birds ([@B19]) which was also exhibited by higher 3-methylhistidine expression in plasma in this study. Since there were no difference in HI *(P* \> 0.05), the ME or NE values contributed from dietary macronutrients remained similar for both the groups.

The RQ, which is the ratio of between the volumes of carbon dioxide produced to the volume of oxygen used, does depend upon the metabolic rate and physiological status of animal. Higher RER values for myopathy broiler could be the outcome of more protein being oxidized or degraded than non-myopathy ([@B20]). RQ of above 0.8 in fed state in both groups showed that dietary calorie values given to these birds were sufficient, whereas \~0.72 for both groups at the unfed state possibly indicate oxidation of ethanol, ketones or lipolysis occurring ([@B21]). Walsberg and Wolf ([@B22]) also reported the RQ value of 0.71 at fasted state which was attributed to incomplete oxidation of fats or non-pulmonary loss of CO2 in the form of bicarbonates.

Microbial characterization showed that there was variation in the abundance of particular genus or species in ileal digesta. *Lactobacillus* that was identified as the predominant genus in this study is ubiquitously inhabiting in nutrient rich ecological niche with more than 200 species and sub species identified ([@B23]), which in another study even reported its potential presence in filet post processing and storage ([@B24]). In myopathy broiler, it could be possible that genus *Lactobacillus* could be going through the greater level of genetic transformation resulting in presentation of higher proportion of unclassified *Lactobacillus* species. Whereas*, L. acidipiscis* was clearly an abundant *Lactobacillus* species in ileal digesta in non-myopathy bird. Prior research done in *L. acidipiscis* in broilers showed the probiotic potential and higher feed efficiency improvement ([@B25]). The species richness was tended to be higher for myopathy group as exhibited by higher value of alpha diversity index; which further could be associated with greater sample-to-sample species variation in myopathy broiler as explained by beta diversity index.

Significant plasma metabolites detected through differential metabolic screening suggested the potential involvement of vascular system in WB myopathy bird. Elevated homocysteine is associated as marker for cardiovascular disease ([@B26]) and can be atherogenic and thrombogenic ([@B27]). Trimethylamine N-oxide also has been associated as pro-atherogenic in humans. It is generated from oxidized trimethylamine (TMA) occurring in gut microbiota, while the precursors for TMA in gut are mainly dietary betaine, L-carnitine, and choline. Microbiota participate in overall immune function and nutrient metabolism of host. The difference in bacterial phylum firmicutes (\~1.55%) between myopathy and non-myopathy broilers could be one potential reason for the resultant difference in TMAO level in plasma ([@B28]). Similarly, another significant plasma metabolite identified was tyramine, which was higher in myopathy broiler. Tyramine is biogenic amine and is a decarboxyted product of tyrosine amino acid. It has both immunological and cardiovascular effects for differences in concentration at pico-nanomolar concentration ([@B29]). Tyramine concentration is affected by dietary as well GI bacteria (tyramine-producing bacteria e.g. *Lactobacillus*), and higher concentration of tyramine is associated with hypertension in humans ([@B29]). The hypertensive and atherogenic effects (of metabolites) could compromise the blood supply in various body tissues including in muscle tissue leading to atrophy and degradation, which could be pathophysiological condition occurring in myopathy bird. As a probable adaptive response to this vascular issue, cyclic GMP was found to be expressed less; the consequence could lead to relaxation of muscle and improvement in vasodilation and circulation ([@B30]). Similarly, other adaptive molecules expressed against the hypertensive and atherogenic effects were carnitine and acetyl carnitine. These compounds are involved in reduction intracellular buildup of toxic metabolites in ischemic condition ([@B31]). Plasma metabolic changes observed in this study in myopathy-affected broiler can be associated with findings from genomic and histological data. A recent study performed in broiler where they studied time series differential expression of genes in WB affected *P. major* using RNAseq showed molecular perturbations involving vasculature in early pathogenesis ([@B32]). Similarly, another study found the genes related to hypoxia were upregulated in WB affected muscle fibers ([@B33]), and microscopical morphometry of vessel density in muscle showed the compromised blood supply in affected tissue ([@B34]). Additionally, *P. major* histological or compositional analysis have exhibited increased lipid content in tissue as an important attribute of muscle myopathy ([@B6], [@B35]--[@B38]). This increased lipidosis in WB affected muscle could be arising from the event of vascular complexity in meat broilers.

In summary, higher growth rate of muscle fibers in breast muscle in modern meat broiler could possibly aid in narrowing down available space (perimysial and endomyisial connective tissue spaces) between muscle fiber bundles thus also limiting the space available for capillaries. This can potentially lead to inadequate removal of metabolic intermediate products, reduced oxygen supply, reduced fiber functionality and increased degenerative myopathy. While microbiota shifts could be one contributing factor in changes in plasma metabolome, the differential metabolic shifts in plasma of myopathy-affected broiler suggested ongoing vascularity issue delivering chronic localized hypoxic condition and subsequent muscle atrophy in P. major. These atrophied muscle specific protein was replaced by collagenous tissue as depicted by histomicrograph results ([Figure 6](#F6){ref-type="fig"}). These pathophysiological and histochemical phenomena occurring in myopathy broiler have caused net loss of muscle protein quality, and quantity, which was evidenced BC, and HP changes particularly for maintenance or fasting HP. The findings of this study warrant the investigations be directed toward improving meat broiler lines that will deliver improved vascularity to alleviate this myopathy condition.

![Micrographs: **(A,B)** Cross-section of *P. major* muscle, MT staining. Micrograph **(A)** has less myodegeneration (non-myopathy broiler) than micrograph **(B)** (myopathy broiler). Micrograph **(A)**: day 41 micrograph demonstrating tightly packed polygonal fibers with a minimal extracellular perimysial and endomysial connective tissue spaces. Connective tissue spaces are wider in micrograph **(B)** as compared to micrograph **(A)**, and the spaces tend to be filled with strands of collagenous tissue (bluish coloration as indicated by white arrow). Greater variation in shape and size of fibers were observed in micrograph B. Relatively more fibrosed and constricted veins in micrograph **(B)** than in micrograph **(A)** (as indicated by yellow arrows).](fvets-06-00497-g0006){#F6}
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